Loading clinical trials...
Loading clinical trials...
A Multi-Center, Open Label Study to Assess the Safety, Steady-State Pharmacokinetics and Pharmacodynamics of IMG-7289 in Patients With Myelofibrosis
Conditions
Interventions
Bomedemstat
Locations
5
United States
University of Michigan
Ann Arbor, Michigan, United States
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Universitatsklinikum Essen
Essen, Germany
Azienda Ospedaliero Universitaria Careggi
Florence, Italy
Guy's and St Thomas' Hospitals
London, United Kingdom
Start Date
July 18, 2017
Primary Completion Date
March 8, 2022
Completion Date
March 8, 2022
Last Updated
January 10, 2024
NCT07357727
NCT06976918
NCT06343805
NCT06859424
NCT05123365
NCT06327100
Lead Sponsor
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions